Related by context. Frequent words. (Click for all words.) 71 multi kinase inhibitor 69 Epratuzumab 69 drug conjugate 68 SAR# [004] 67 elotuzumab 67 liposomal formulation 67 humanized anti 67 Onalta 67 nicotinic alpha 7 67 HGS ETR1 67 MEK inhibitor 67 Panzem R 66 PEG SN# 66 humanized antibody 66 phase IIb clinical 66 CCX# 66 ALN TTR# 66 HCV protease inhibitor 66 Tesetaxel 66 humanized monoclonal antibody 66 Elesclomol 65 Panitumumab 65 dependent cellular cytotoxicity 65 MVA BN R 65 Traficet EN 65 oncolytic 65 Bavituximab 65 BiTE antibody 65 Ofatumumab 65 IMC A# 64 cancer immunotherapies 64 anti CD# monoclonal 64 non alcoholic steatohepatitis 64 Sym# 64 Zolinza 64 Voreloxin 64 RGB # 64 KNS # 64 OncoVEX GM CSF 64 mTOR inhibitor 64 epothilone 64 metastatic hormone refractory 64 tyrosine kinase inhibitor 64 orally bioavailable 64 Azedra 64 drug conjugate ADC 64 CYC# 64 atacicept 64 anticancer compound 64 Medarex logo 64 Allovectin 7 R 64 Cethromycin 64 Monoclonal Antibody 63 GSK # 63 forodesine 63 registrational trial 63 immunotherapeutic 63 Nexavar ® 63 otelixizumab 63 R sorafenib tablets 63 novel orally administered 63 multiple myeloma MM 63 Amrubicin 63 therapeutic monoclonal antibodies 63 Laquinimod 63 Carfilzomib 63 HCV protease 63 nitric oxide donating 63 ALN VSP 63 Presents Positive 63 OXi# 63 CR# vcMMAE 63 IIa trial 63 registrational 63 luteinizing hormone releasing 63 MKC# 63 AeroLEF R 63 human monoclonal antibody 63 Phase III Clinical Trial 63 ONCONASE 63 BAL# [001] 63 FGFR 63 AVE# 63 ZALBIN 62 EndoTAG TM -1 62 Phase IIb trials 62 Guanilib 62 Pirfenidone 62 Idera Pharmaceuticals 62 relapsed multiple myeloma 62 ApoB SNALP 62 ganetespib 62 NVA# 62 subcutaneous formulation 62 Inc. Nasdaq IMGN 62 ATL# [001] 62 Diamyd ® 62 pertuzumab 62 REMUNE R 62 fusion inhibitor 62 Aliskiren